Archives
-
Phosbind Acrylamide for Phosphorylation Analysis
2026-09-22
Phosbind Acrylamide enables antibody-free separation of phosphorylated and non-phosphorylated proteins directly in SDS-PAGE. This practical guide applies the approach to kinase assays and jasmonate-regulated plant signaling, with optimization controls for reliable mobility-shift interpretation.
-
p-Cresyl Sulfate: From Uremic Toxin to Valve Risk
2026-09-22
p-Cresyl sulfate is emerging as more than a retention marker in chronic kidney disease. This thought-leadership article connects endothelial dysfunction, valvular calcification, klotho/SIRT1 signaling, and translational assay design to guide cardiovascular and renal researchers.
-
ARCA EGFP mRNA: From Signal to Confidence
2026-09-21
A thought-leadership guide to using ARCA EGFP mRNA as a mechanistically informed mRNA transfection control, linking direct fluorescence readouts with cell-context biology, delivery-system benchmarking, and translational assay strategy.
-
IEM 1460: AMPA Receptor Blocker Workflows
2026-09-21
IEM 1460 enables selective AMPA receptor inhibition assays that separate fast glutamatergic signaling from broader neurotoxicity effects. This workflow guide translates recent glutamate-receptor research into practical assay design, dose-finding, neuroprotection testing, and troubleshooting strategies.
-
Deferiprone as a Precision Iron-Stress Probe
2026-09-20
Deferiprone, also known as 3-hydroxy-1,2-dimethylpyridin-4-one, is more than an iron chelator: it is a tunable probe for linking iron availability to proliferation, metabolism, redox balance, and apoptosis. This article translates enterocyte metabolomics into practical assay design for cancer biology and neurovascular research.
-
SP2509: Lysine-Specific Demethylase 1 Antagonist
2026-09-19
SP2509 is a Lysine-specific demethylase 1 antagonist with a reported LSD1 enzymatic IC50 of 13 nM. Its research profile includes CoREST disruption, promoter-specific H3K4Me3 elevation, apoptosis induction in AML cells, and differentiation effects in acute myeloid leukemia models.
-
SepM Mutations and S. mutans–S. gordonii Inhibition
2026-09-18
Liu et al. linked recurrent sepM missense mutations in clinical Streptococcus mutans isolates with stronger inhibition of Streptococcus gordonii and examined how selected substitutions alter SepM–CSP-21 binding. The work combines isolate-level genetics, expression analysis, recombinant protein studies, and pH-dependent affinity measurements to connect bacterial variation with interspecies competition.
-
IAM LC vs LEKC for Pulmonary Drug Permeability
2026-09-18
The reference study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for modelling drug–membrane partitioning and pulmonary permeability. Its results show that LEKC can better reflect phospholipid-mediated interactions and lung permeability, whereas IAM LC offers broader compound coverage, simpler operation, and stronger suitability for automated screening.
-
Two Flavone 2′-Glucosides from Scutellaria baicalensis
2026-09-17
The 1995 reference study established two previously unreported flavone 2′-O-glucosides from Scutellaria baicalensis roots and identified seven additional phenolics, including baicalin methyl ester. Its value is primarily phytochemical: chromatographic isolation and multidimensional spectral analysis authenticated structures that can now serve as starting points for mechanistic studies, while the paper itself did not test intestinal barrier activity or anti-inflammatory effects.
-
Anagliptin (SK-0403): DPP-4 and Vascular Mechanisms
2026-09-17
Anagliptin (SK-0403) is an orally active DPP-4 inhibitor with a reported IC50 of 3.8 nM. In rabbit aortic rings, the compound produced vasorelaxation associated with Kv channel and SERCA pump activity, while classic cyclic-nucleotide pathways and the endothelium were not required.
-
Diuron: From Photosynthesis to Renal Toxicology
2026-09-16
Diuron is both a mechanistically defined photosynthesis inhibitor and a valuable model for environmental toxicology. This article presents an assay-translation framework linking its plant target to emerging evidence on JAK2/STAT1-associated renal injury.
-
Dehydroepiandrosterone (DHEA) Experimental Workflows
2026-09-16
Build reproducible DHEA workflows for PCOS models, granulosa-cell apoptosis, macrophage-conditioned media, and neuroprotection studies. This guide connects dose selection and vehicle control with practical assays for granulosa cell proliferation, hippocampal neuron protection, and apoptosis inhibition.
-
Gemini Quaternary Ammonium Compounds: Study Insights
2026-09-15
The reference study synthesizes 16 novel octenidine-derived gemini quaternary ammonium compounds and evaluates their antibacterial, antibiofilm, antifungal, antiviral, and cytotoxicity profiles. Compounds 1 and 12 were especially notable for fungal selectivity or broad-spectrum activity, while the structure–activity analysis illustrates how polarity and molecular design can improve the performance of antiseptic research compounds.
-
Tioconazole (B2051) in Reproducible Fungal Assays
2026-09-15
This scenario-driven guide explains how Tioconazole, SKU B2051, can improve solvent control, dose preparation, and interpretation in fungal viability and cytotoxicity workflows. It links product specifications with practical assay design while distinguishing validated antifungal evidence from exploratory cross-domain applications.
-
Iron Stress Reprograms Enterocyte Metabolism
2026-09-14
Navazesh and Ji used IPEC-J2 enterocytes to show that both iron deficiency and iron excess produce distinct metabolic and transcriptional programs. The study links iron deficiency to impaired proliferation, altered central carbon metabolism, and inflammatory signaling, while iron excess favors cholesterol synthesis and lowers alpha-tocopherol, with partial recovery after iron repletion.